As of 4:00pm ET
| +0.70 / +2.77%|
The 7 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 36.00, with a high estimate of 80.00 and a low estimate of 27.00. The median estimate represents a +38.46% increase from the last price of 26.00.
The current consensus among 8 polled investment analysts is to Buy stock in AMAG Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.